Literature DB >> 2667929

Potential role of phospholipid-signaling systems in insulin action and states of clinical insulin resistance.

R V Farese1, D R Cooper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2667929     DOI: 10.1002/dmr.5610050504

Source DB:  PubMed          Journal:  Diabetes Metab Rev        ISSN: 0742-4221


× No keyword cloud information.
  6 in total

Review 1.  Cardiomyopathy associated with noninsulin-dependent diabetes.

Authors:  S W Schaffer
Journal:  Mol Cell Biochem       Date:  1991-09-18       Impact factor: 3.396

2.  Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B.

Authors:  G I Welsh; C G Proud
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

3.  Growth hormone inhibits activation of phosphatidylinositol phospholipase C in adipose plasma membranes: evidence for a growth hormone-induced change in G protein function.

Authors:  P Roupas; S Y Chou; R J Towns; J L Kostyo
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

4.  Signal transduction mechanism for the stimulation of the sarcolemmal Na(+)-Ca2+ exchanger by insulin.

Authors:  C Ballard; M Mozaffari; S Schaffer
Journal:  Mol Cell Biochem       Date:  1994-06-15       Impact factor: 3.396

5.  Comparison of the effects of insulin and okadaic acid on phosphoenolpyruvate carboxykinase gene expression.

Authors:  R M O'Brien; E L Noisin; D K Granner
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

6.  Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes.

Authors:  R M O'Brien; E L Noisin; A Suwanichkul; T Yamasaki; P C Lucas; J C Wang; D R Powell; D K Granner
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.